搜索临床试验以:IBI110 Sintilimab
总计566个结果
-
Innovent Biologics (Suzhou) Co. Ltd.终止
-
Innovent Biologics (Suzhou) Co. Ltd.尚未招聘
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Peking UniversityInnovent Biologics (Suzhou) Co. Ltd.未知
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.撤销
-
The First Affiliated Hospital of Zhengzhou University尚未招聘
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Innovent Biologics (Suzhou) Co. Ltd.主动,不招人
-
Innovent Biologics (Suzhou) Co. Ltd.招聘中
-
West China HospitalSichuan Provincial People's Hospital; The First People's Hospital of Ziyang; Chengdu City No.2... 和其他合作者尚未招聘
-
Innovent Biologics (Suzhou) Co. Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...招聘中Sintilimab, Cetuximab, Regorafenib,Combine,mCRC中国
-
Sixth Affiliated Hospital, Sun Yat-sen UniversitySun Yat-sen University招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Second Affiliated Hospital of Guangzhou Medical...完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中